News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Baxter International, Inc. (BAX) Pump Recall Gets FDA's Highest-Risk Label Following 9 Severe Injuries



5/5/2014 7:19:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Baxter's infusion pump recall is associated with 9 severe adverse events and more than 3,500 complaints, getting the FDA's attention and highest-risk warning label. Medtech maker Baxter (NYSE:BAX) got the FDA's highest-risk warning after recalling a series of infusion pumps due to a software issue that could lead the devices to malfunction. The recall affects 2 models of Sigma Spectrum Infusion Pumps pumps, manufactured from July 1, 2005, through January 15, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES